Melatonin for the Treatment of Insomnia: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines [Internet]

Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb 22.


The objective of this report is to summarize the evidence regarding the clinical effectiveness, cost-effectiveness, and guidelines pertaining to the use of melatonin for the treatment of insomnia in adults.

Publication types

  • Review

Grant support

Funding: CADTH receives funding from Canada’s federal, provincial, and territorial governments, with the exception of Quebec.